RESEARCH ATLAS
← Compound index
COMPOUND RECORD / DELTARAN

DeltaranДельтаран

PerformanceStressRecovery
Source linked
01 / OVERVIEW

About Deltaran

Names in this research collection

Deltaran DSIP · Delta sleep-inducing peptide with glycine

A formulation containing delta sleep-inducing peptide and glycine. The linked behavioral and blood-marker studies evaluated the formulation.

Research background

A formulation containing delta sleep-inducing peptide and glycine. The linked behavioral and blood-marker studies evaluated the formulation.

What the studies found

Animal research · 2006

Who or what was studiedLaboratory animals in conditioned avoidance and locomotor behavior experiments. Group sizes unverified.

Reported finding

The abstract reports changes in acquisition and retention of an active swimming-avoidance response, more spontaneous movement and less freezing with Deltaran.

Conditioned swimming avoidance
Acquisition and retention changedThe original abstract gives no numerical effect or group size.
Spontaneous behavior
More horizontal and vertical movement and less time freezingDirection only from the original abstract. Swimming was an avoidance task.
All reported results & study design →
Methods, dose & source notes

Study of multiple preparations · Medline.ru. 7:47–54, article 5

Deltaran contains DSIP and glycine. The contribution of isolated DSIP was not established. Original dose, groups and numerical outcomes remain unverified.

Deltaran and avoidance learning in animals ↗

Animal research · 2017

Who or what was studiedMale and female laboratory rats. The abstract prints n=6 per group.

Reported finding

Plasma superoxide dismutase activity increased 28.6% in male rats and 21.1% in females compared with controls.

Plasma superoxide dismutase activity
+28.6% in males and +21.1% in femalesp<0.05 as reportedVersus corresponding controls.
Plasma protein and total lipids
Protein +14.8% in males and total lipids +20.2% in femalesp<0.05 as reportedVersus corresponding controls. The reverse sex-specific comparisons showed no reported difference.
Female plasma phospholipid share
−21.3%Share of plasma lipids, a separate measure from total lipids.
All reported results & study design →
Methods, dose & source notes

Study of multiple preparations · Reviews of Clinical Pharmacology and Drug Therapy. 15(Suppl. 2):21–22

Small conference experiment and an unusually high printed formulation dose. No performance, endurance or human endpoint was measured.

Deltaran and plasma superoxide dismutase in rats ↗

These highlights cover selected studies. Open a source for its methods, reported doses and full context.

Compound class
DSIP and glycine formulation
Research collection
Actoprotection & occupational pharmacology · editorial grouping
Research institutions
No institutional affiliation recorded
Source review
Review dates and the material assessed are listed with each publication below.
02 / HOW TO READ THE RESEARCH

Understanding the evidence

Human research

The linked performance-related studies used animals.

Study methods

Conditioned avoidance, open-field behavior and plasma antioxidant enzymes.

Independent replication

Independent replication is not established in the linked sources.

Source access

Original sources and the exact review scope are linked below.

Safety evidence

The linked experiments do not establish a safe human performance regimen.

Open a topic for the evidence assessment.

More findings, background and history
EVIDENCE REVIEW / 6 OCTOBER 2026

Outstanding review questions

Appraise original methods and replication; keep animal and cell findings separate from unestablished human benefit and safety.

No human intervention report has been identified among the linked records; unclassified archival leads may remain. Publication records can share participants. Source counts are not trial counts.

Browse original study records ↗
03 / SOURCE RECORDS

Linked sources

Explore the research map and unresolved leads ↗

2006 · Deltaran and avoidance learning in animalsConditioned swimming avoidance: Acquisition and retention changed
2006Animal / experimentalRussian source · see review scope

Deltaran and avoidance learning in animals

· Medline.ru. 7:47–54, article 5

Format: Original journal abstract. Full PDF tables unavailable. · Reviewed: Reported methods, results and evidence limitations

G. G. Dmitriev, E. Yu. Bonitenko, M. B. Ivanov, V. A. Basharin · Medline.ru. 7:47–54, article 5

The abstract reports changes in acquisition and retention of an active swimming-avoidance response, more spontaneous movement and less freezing with Deltaran.

Findings, study figures and available tables

Reported findings and study design

The abstract reports changes in acquisition and retention of an active swimming-avoidance response, more spontaneous movement and less freezing with Deltaran.

Laboratory animals in conditioned avoidance and locomotor behavior experiments. Group sizes unverified.

Reported findings and study figures · Original journal abstract. Full PDF tables unavailable.
MeasureResultComparison, timing and statistics
Conditioned swimming avoidanceAcquisition and retention changedThe original abstract gives no numerical effect or group size.
Spontaneous behaviorMore horizontal and vertical movement and less time freezingDirection only from the original abstract. Swimming was an avoidance task.

An animal learning and behavior experiment. Its abstract supplies no athletic endurance endpoint.

Source for the extracted data ↗ · Checked 2026-11-09

Population / setting
Laboratory animals in conditioned avoidance and locomotor behavior experiments. Group sizes unverified.
What was checked
Original journal abstract. Full PDF tables unavailable.
Limitations & review scope
  • Deltaran contains DSIP and glycine. The contribution of isolated DSIP was not established. Original dose, groups and numerical outcomes remain unverified.

Source checked 2026-11-09. See the review scope above for the material assessed.

Read the source ↗
2017 · Deltaran and plasma superoxide dismutase in ratsPlasma superoxide dismutase activity: +28.6% in males and +21.1% in females
2017Animal / experimentalFull text available

Deltaran and plasma superoxide dismutase in rats

· Reviews of Clinical Pharmacology and Drug Therapy. 15(Suppl. 2):21–22

Format: Original 2017 Regulatory Neuropeptides conference abstract, pp. 21–22 · Reviewed: Reported methods, results and evidence limitations

S. G. Dagaev, L. G. Kubarskaya, V. A. Kashuro · Reviews of Clinical Pharmacology and Drug Therapy. 15(Suppl. 2):21–22

Plasma superoxide dismutase activity increased 28.6% in male rats and 21.1% in females compared with controls.

Findings, study figures and available tables

Reported findings and study design

Plasma superoxide dismutase activity increased 28.6% in male rats and 21.1% in females compared with controls.

Male and female rats received intranasal Deltaran for five days and were compared with controls. The abstract reports six per group and measures plasma protein, lipids and antioxidant enzyme activity.

Protocol information

Intranasal Deltaran for five days. The abstract prints 150 mg/kg for the formulation. The unit and the mass of isolated DSIP are unconfirmed.

Protocol source ↗ · Original 2017 Regulatory Neuropeptides conference abstract, pp. 21–22

Reported findings and study figures · Original 2017 Regulatory Neuropeptides conference abstract, pp. 21–22
MeasureResultComparison, timing and statistics
Plasma superoxide dismutase activity+28.6% in males and +21.1% in femalesVersus corresponding controls. · p<0.05 as reported
Plasma protein and total lipidsProtein +14.8% in males and total lipids +20.2% in femalesVersus corresponding controls. The reverse sex-specific comparisons showed no reported difference. · p<0.05 as reported
Female plasma phospholipid share−21.3%Share of plasma lipids, a separate measure from total lipids.

These biomarker changes describe the tested DSIP-plus-glycine formulation.

Source for the extracted data ↗ · Checked 2026-11-09

Population / setting
Male and female laboratory rats. The abstract prints n=6 per group.
What was checked
Original 2017 Regulatory Neuropeptides conference abstract, pp. 21–22
Limitations & review scope
  • Small conference experiment and an unusually high printed formulation dose. No performance, endurance or human endpoint was measured.

Source checked 2026-11-09. See the review scope above for the material assessed.

Read the source ↗

Follow shared publications or research classes. These links do not establish equivalent effects between compounds.

DSIP research ↗

2 shared source records

Research collection curated by @PepMariner · editorial standards. Send a source correction ↗

Browse bibliography & PDFs ↗